Centre Eyes Price Caps on Medical Devices Amid Scrutiny of Private Hospital Billing Practices

New Delhi: Private hospitals across India have come under increased scrutiny from the Government of India amid growing concerns over rising healthcare costs and alleged overcharging for medical devices and treatments.

According to reports, the Ministry of Health and Family Welfare is actively evaluating measures to regulate hospital billing practices. One of the key proposals under consideration involves capping trade margins on a wide range of medical devices to curb excessive pricing and improve affordability for patients.

As part of the proposed framework, hospitals may be restricted from charging beyond a fixed margin over the procurement or landing cost of medical devices. The move is aimed at ensuring greater pricing transparency and reducing the financial burden on patients. To assess the feasibility of such regulations, the government is currently engaging in consultations with key stakeholders, including insurance providers and representatives from the medical device industry.

The proposed pricing caps are expected to cover both low-cost, high-volume consumables—such as syringes, cannulas, and gloves—as well as high-value medical equipment, including pacemakers and heart valves.

Allegations of Excessive Billing

The policy push follows mounting evidence suggesting significant markups by private hospitals on medical supplies. Investigations indicate that certain items are billed at multiples far exceeding their actual cost. For instance, a syringe priced at ₹3 may be billed at ₹30, while an IV cannula costing approximately ₹6 could be charged at ₹120.

Similar pricing disparities have reportedly been observed in high-end medical devices. Pacemakers with a base cost of around ₹25,000 are said to be billed at nearly ₹2 lakh, while imported heart valves costing approximately ₹4 lakh have been charged as high as ₹26–30 lakh in some cases.

Impact on Health Insurance Sector

The escalating cost of medical treatment is also exerting pressure on the health insurance industry. Experts estimate that insurance premiums could rise by 10–15% over the next 12 to 18 months, driven by sustained medical inflation currently pegged at an annual rate of 14–15%.

Key factors contributing to rising insurance costs include increased hospital charges, the adoption of advanced medical technologies, and a higher frequency of claims. The proposed regulatory measures are therefore expected not only to protect patients but also to stabilise the broader healthcare financing ecosystem.

If implemented, the margin caps could mark a significant step toward improving accountability and cost efficiency in India’s private healthcare sector.